Skip to main content

Diabetes

  • Diabetes drug from Lilly, BI hits shelves

    INDIANAPOLIS — A new drug for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim is available in pharmacies, the companies said Wednesday.

    The two companies announced the availability of Jentadueto (linagliptin and metformin hydrochloride). The Food and Drug Administration approved the drug on Jan. 30.

  • NCPA brings back diabetes management, long-term care workshops

    ALEXANDRIA, Va. — The National Community Pharmacists Association has renewed two of its pharmacy niche programs.

  • Walgreens: Face-to-face consults with pharmacists, retail clinicians reduce health spend

    LAS VEGAS — Walgreens last week outlined how the company's research has demonstrated the ability of face-to-face pharmacy and Take Care Clinic programs to drive better health outcomes at the IMS Managed Markets Services/Data Niche Conference held here.

    Some of the savings advantages inherent in the offerings provided by Walgreens include:

  • Study: Canadians turning to local pharmacies for more health care

    TORONTO — Patients in Canada increasingly are tapping into the healthcare knowledge, expertise and services available at their local pharmacy, with many of them talking to their pharmacist about one or more healthcare issues other than filling a prescription, according to the findings of a new Nielsen survey commissioned by the Canadian Association of Chain Drug Stores.

  • American Diabetes Association responds to FDA's warning on safety of statins

    ALEXANDRIA, Va. — The American Diabetes Association said it is urging people with diabetes who currently are taking a statin to continue their medication unless instructed otherwise by their healthcare provider.

  • UnitedHealth Group, Comcast launch pilot to evaluate video-on-demand programming for Diabetes Prevention Program

    PHILADELPHIA — UnitedHealth Group is looking to evaluate the effectiveness of using video-on-demand programming to deliver its Diabetes Prevention Program.

    The insurance company has tapped Comcast to find participants for the study, which will be test marketed in Philadelphia, and Knoxville, Tenn. Enrollment began on Feb. 13; the first VOD programming will be available Feb. 27.

  • Sam's Club launches wellness magazine for members

    BENTONVILLE, Ark. — Sam's Club is taking its promotion of health-and-wellness solutions further by launching its own branded, bimonthly magazine.

    Sam' Club said its 8-million member circulation magazine, Healthy Living Made Simple, is the first warehouse club publication solely dedicated to health-and-wellness issues. Topics covered by the publication include items related to personal, child and pet health. Future issues will spotlight local Sam’s Club pharmacists, optometrists and associates, as well as members’ stories, Sam's Club said.

  • Takeda's investigational diabetes drug helps reduce HbA1C levels

    DEERFIELD, Ill. — An investigational diabetes therapy made by Takeda helped lower HbA1C levels among patients with Type 2 diabetes, the drug maker said.

X
This ad will auto-close in 10 seconds